TOPK Inhibition | TOPK Inhibitor | TOPK Inhibitor Review

Catalog No.	Product Name	Information	Product Use Citations
S7652	OTS514 hydrochloride	OTS514 is a highly potent TOPK(T-LAK cell-originated protein kinase) inhibitor with an IC50 value of 2.6 nM. OTS514 induces cell cycle arrest and apoptosis.	Exp Mol Med, 2022, 54(7):999-1010 Mol Oncol, 2021, 15(12):3721-3737 Oncogenesis, 2021, 10(1):9
S7648	OTS964	OTS964 is a potent TOPK inhibitor with high affinity and selectivity and IC50 value is 28 nM. OTS964 is also a potent inhibitor of the cyclin-dependent kinase CDK11 with Kd of 40 nM. OTS964 treatment activates autophagy in glioma cells and induces apoptosis of human lung cancer cells in mouse xenografts.	Nucleic Acids Res, 2023, gkad001 Cancer Lett, 2022, 544:215812 Cell Death Dis, 2022, 13(5):450
S6882	HI-TOPK-032	HI-TOPK-032 is a potent and specific inhibitor of TOPK. HI-TOPK-032 also reduces ERK-RSK phosphorylation, regulates of the abundance of p53, cleaved caspase-7, and cleaved PARP, and induces apoptosis in cancer cells.
S7652	OTS514 hydrochloride	OTS514 is a highly potent TOPK(T-LAK cell-originated protein kinase) inhibitor with an IC50 value of 2.6 nM. OTS514 induces cell cycle arrest and apoptosis.	Exp Mol Med, 2022, 54(7):999-1010 Mol Oncol, 2021, 15(12):3721-3737 Oncogenesis, 2021, 10(1):9
S7648	OTS964	OTS964 is a potent TOPK inhibitor with high affinity and selectivity and IC50 value is 28 nM. OTS964 is also a potent inhibitor of the cyclin-dependent kinase CDK11 with Kd of 40 nM. OTS964 treatment activates autophagy in glioma cells and induces apoptosis of human lung cancer cells in mouse xenografts.	Nucleic Acids Res, 2023, gkad001 Cancer Lett, 2022, 544:215812 Cell Death Dis, 2022, 13(5):450
S6882	HI-TOPK-032	HI-TOPK-032 is a potent and specific inhibitor of TOPK. HI-TOPK-032 also reduces ERK-RSK phosphorylation, regulates of the abundance of p53, cleaved caspase-7, and cleaved PARP, and induces apoptosis in cancer cells.

TOPK

TOPK Products

Choose Selective TOPK Inhibitors